Search results for abx831561

Retifanlimab, Abbexa, abx831561

Retifanlimab is a monoclonal antibody biosimilar expressed in CHO cells, targeting PDCD1/PD1/CD279, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Retifanlimab (INCMGA-0012) is an anti-PD-1 monoclonal antibody. INCMGA0012 is currently in the clinical proof-of-concept (PoC) stage. At the same time, Incyte is exploring the efficacy of INCMGA0012 monotherapy in high satellite unstable endometrial cancer and Merkel cell carcinoma.